The ESMO presentation everyone’s been waiting for
Moderna and Merck's 'presidential' presentation, and other news from Day 2 of the European Society for Medical Oncology meeting in Madrid.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by STAT News; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersIn data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred.
By Chella·22h ago
Why it mattersThe American Diabetes Association has issued two explanations, two reviews and an apology over its June convention. A Friday report adds new twists.
By Chella·22h ago
Why it matters“Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes a STAT reader.
By Chella·7h ago
Why it matters“The goal is not simply to diagnose MS faster. It is to get the diagnosis right,” writes Bruce Bebo.
By Chella·7h ago